 |
|
New Directions in Metastatic CRC Treatment: Roundtable Discussions
Advances in therapeutic and diagnostic techniques as well as the availability of several new active agents have revolutionized the treatment of CRC in recent years. This symposium will present pivotal research developments in CRC, including emerging data on novel agents, positive and negative predictors of response to these agents, and how this information may ultimately translate into individualized patient treatment and improved outcomes.
A CRC physician key opinion leader will begin the symposium with an overview of treatment standards and outstanding clinical questions. As the principles of adult learning are often breached by the inability of participants to engage thought leaders and colleagues in the discussion of questions, practice patterns, and complicated patient scenarios, following this overview, IMER will provide a dynamic learning opportunity via intimate roundtable discussions on three actual patients with CRC: newly diagnosed advanced CRC, recurrent metastatic CRC, and CRC with liverlimited metastases. At each roundtable, CRC treatment standards of care based on disease stage, patient performance status, age, previous treatment exposure, and genetic factors will be discussed as they relate to the pertinent case. Because this program is dedicated to oncology nursing practice, symptom management will be a major focus.
|